Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.
J&J heads to FDA for Vyvgart competitor; Tokyo conglomerate launches venture fund
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS